A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In adults with low vitamin D, 8 weeks of omega-3 supplementation lowered the ACE/ACE2 blood marker ratio but also raised LDL cholesterol.
In children with sickle cell disease, adding omega-3 to standard therapy was linked to fewer and less severe pain crises than standard therapy alone.
In cell and mouse studies, combining omega-3 fatty acids with the drug rapamycin increased cancer cell death and reduced the drug's metabolic side effects.
In a Japanese population, fish-related blood and urine metabolites were linked to lower triglycerides, lower blood pressure, and higher HDL cholesterol, with the strongest effects seen for raw and high-omega-3 fish.
Across 16 UK Biobank studies, higher blood levels of omega-3s and DHA were consistently linked to lower risk of heart disease, stroke, fatty liver disease, and type 2 diabetes.
High-dose EPA+DHA supplementation improved insulin resistance and lowered inflammatory markers in women with obesity, but most benefits faded within a month after stopping, except for insulin-related and immune gene changes which lasted longer.